Diagnostic yield of push-type enteroscopy in relation to indication

por Landi, B, Tkoub, M, Gaudric, M, Guimbaud, R, Cervoni, J, Chaussade, S, Couturier, D, Barbier, J, Cellier, C
Publicado 1998

The prognostic impact of immune-related adverse events during anti-PD1 treatment in melanoma and non–small-cell lung cancer: a real-life retrospective study

por Dupont, R., Bérard, E., Puisset, F., Comont, T., Delord, J.-P., Guimbaud, R., Meyer, N., Mazieres, J., Alric, L.
Publicado en Oncoimmunology (2019)

A phase I clinical and pharmacokinetic study of capecitabine (Xeloda®) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours

por Delord, J P, Pierga, J Y, Dieras, V, Bertheault-Cvitkovic, F, Turpin, F L, Lokiec, F, Lochon, I, Chatelut, E, Canal, P, Guimbaud, R, Mery-Mignard, D, Cornen, X, Mouri, Z, Bugat, R
Publicado 2005

Hydroxychloroquine in COVID-19 patients: what still needs to be known about the kinetics

por Martin-Blondel, G, Ruiz, S, Murris, M, Faguer, S, Duhalde, V, Eyvrard, F, Izopet, J, Mansuy, J M, Rolland, Y, Delavigne, K, Guimbaud, R, Pugnet, G, Conil, J M, Georges, B, Delobel, P, Minville, V, Silva Sifontes, S, Concordet, D, Gandia, P
Publicado en Clin Infect Dis (2020)

PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorec...

por Mineur, L., François, E., Plassot, C., Phelip, J. M., Miglianico, L., Dourthe, L. M., Bonichon, N., Moreau, L., Guimbaud, R., Smith, D., Achille, E., Hervé, R., Bons, J. M., Remy, S., Faroux, R., Villing, A. L., Mahamat, A., Rabbia, I., Soulié, P., Baumgaertner, I., Mathé, N., Vazquez, L., Boustany, R.
Publicado en PLoS One (2020)